152 filings
6-K
CYTO
Altamira Therapeutics Ltd
16 Apr 24
Notice of the Annual General Meeting of Shareholders
5:00pm
6-K
CYTO
Altamira Therapeutics Ltd
10 Apr 24
Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results
8:30am
6-K
CYTO
Altamira Therapeutics Ltd
19 Jan 24
Report of Foreign Private Issuer
4:45pm
6-K
CYTO
Altamira Therapeutics Ltd
19 Jan 24
Report of Foreign Private Issuer
4:30pm
6-K
CYTO
Altamira Therapeutics Ltd
11 Dec 23
Altamira Therapeutics Provides Investor and Business Update
8:01am
6-K
ofhci
11 Dec 23
Report of Foreign Private Issuer
8:00am
6-K
4447t fkx
8 Dec 23
Report of Foreign Private Issuer
9:00am
6-K
8d0vfcm ys0mik2y
22 Nov 23
Report of Foreign Private Issuer
4:30pm
6-K
yuq6akgcy
21 Nov 23
Report of Foreign Private Issuer
8:00am
6-K
451t7jih
31 Oct 23
Report of Foreign Private Issuer
4:30pm
6-K
40ny9xu
4 Oct 23
Notice of the Special General Meeting of Shareholders
9:00am
6-K
8t2yo
12 Sep 23
Report of Foreign Private Issuer
7:30am
6-K/A
z9w 5oo233vtovgott59
21 Aug 23
Current report (foreign) (amended)
7:31am
6-K
sdswyruwss5 nf8p
28 Jul 23
Current Report
7:00am
6-K
wtugn2mdtn3xzr0rp
26 Jul 23
Report of Foreign Private Issuer
9:00am
6-K
nmontjubds10
11 Jul 23
Altamira Therapeutics Announces Pricing of $5.0 Million Public Offering
8:32am
6-K
9dva8sqb
3 Jul 23
Report of Foreign Private Issuer
7:11pm
6-K
hgod 0f0clai23
30 Jun 23
Report of Foreign Private Issuer
6:30am
6-K
anvdpvuv f12k64f
27 Jun 23
Current Report
4:45pm
6-K
6is64 zirpt4drqn34k8
15 Jun 23
Altamira Therapeutics Announces IND Clearance by U.S. FDA for AM-125 in Acute Vestibular Syndrome
4:30pm